Home > Result Summaries: Compounds > abacavir/lamivudine > Result Summary for 112885_4

Result Summary for 112885_4

Result Summary

Protocol ID:	112885_4
Clinical Study ID:	WWE112885
Official Title:	Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy
Phase:	N/A
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus
Generic Name:	abacavir/lamivudine
Trade/Product Name:	Epzicom
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	The Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy registry International Interim report for 1 January 1989 through 31 January 2010. Wilmington, NC: Registry Coordinating Center; 2010. Available from URL: www.APRegistry.com